Pexacerfont

98%

  • Product Code: 101922
  CAS:    459856-18-9
Molecular Weight: 340.42 g./mol Molecular Formula: C₁₈H₂₄N₆O
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: 2-8℃
Product Description: Pexacerfont is primarily investigated for its potential therapeutic applications in the treatment of anxiety and stress-related disorders. It functions as a corticotropin-releasing factor type 1 (CRF1) receptor antagonist, which plays a key role in regulating the body's stress response. By blocking this receptor, it may help reduce symptoms of anxiety and depression, offering a novel approach to managing these conditions. Clinical studies have explored its efficacy in alleviating stress-induced behaviors, making it a promising candidate for future psychiatric treatments. Its targeted mechanism could provide a more specific and potentially safer alternative to traditional anxiolytics.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.001 10-20 days ฿5,530.00
+
-
0.005 10-20 days ฿13,910.00
+
-
0.025 10-20 days ฿35,920.00
+
-
Pexacerfont
Pexacerfont is primarily investigated for its potential therapeutic applications in the treatment of anxiety and stress-related disorders. It functions as a corticotropin-releasing factor type 1 (CRF1) receptor antagonist, which plays a key role in regulating the body's stress response. By blocking this receptor, it may help reduce symptoms of anxiety and depression, offering a novel approach to managing these conditions. Clinical studies have explored its efficacy in alleviating stress-induced behaviors, making it a promising candidate for future psychiatric treatments. Its targeted mechanism could provide a more specific and potentially safer alternative to traditional anxiolytics.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: ฿0.00
฿0.00 Total :